| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LUMOS PHARMA, INC. | Chief Financial Officer | Common Stock | 0 | $0 | $1.89 | 12 Dec 2024 | Direct |
| LUMOS PHARMA, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 12 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| (LUMO) | LUMOS PHARMA, INC. | 12 Dec 2024 | 10 | $0 | 4 | Chief Financial Officer | 13 Dec 2024, 21:30 |
| (LUMO) | LUMOS PHARMA, INC. | 01 Aug 2024 | 1 | -$410 | 4 | Chief Financial Officer | 05 Aug 2024, 17:19 |
| (LUMO) | LUMOS PHARMA, INC. | 01 Apr 2024 | 3 | +$2,062 | 4 | Chief Financial Officer | 03 Apr 2024, 17:11 |
| (LUMO) | LUMOS PHARMA, INC. | 01 Feb 2024 | 1 | -$647 | 4 | Chief Financial Officer | 05 Feb 2024, 17:53 |
| LUMO | LUMOS PHARMA, INC. | 01 Aug 2023 | 1 | -$751 | 4 | Chief Financial Officer | 03 Aug 2023, 16:58 |
| LUMO | LUMOS PHARMA, INC. | 01 Apr 2023 | 1 | -$907 | 4 | Chief Financial Officer | 04 Apr 2023, 17:21 |
| LUMO | LUMOS PHARMA, INC. | 01 Feb 2023 | 3 | +$3,119 | 4 | Chief Financial Officer | 03 Feb 2023, 16:03 |
| LUMO | LUMOS PHARMA, INC. | 01 Aug 2022 | 1 | -$1,871 | 4 | Chief Financial Officer | 03 Aug 2022, 11:25 |
| LUMO | LUMOS PHARMA, INC. | 01 Apr 2022 | 1 | -$2,529 | 4 | Chief Financial Officer | 05 Apr 2022, 17:28 |
| LUMO | LUMOS PHARMA, INC. | 01 Feb 2022 | 3 | +$9,369 | 4 | Chief Financial Officer | 03 Feb 2022, 15:36 |
| LUMO | LUMOS PHARMA, INC. | 01 Aug 2021 | 2 | $0 | 4 | Chief Financial Officer | 03 Aug 2021, 18:09 |